Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Drug Safety|November 5, 2011
Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agenciesIneke Crijns, Sabine Straus, Michiel Luteijn, et al.
Pharmacoepidemiology and Drug Safety|August 2, 2024
Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and RecommendationsThomas Goedecke, Liana Martirosyan, Nathalie Gault, et al.
International Journal of Clinical Pharmacy|December 10, 2014
Evaluating performance of electronic healthcare records and spontaneous reporting data in drug safety signal detectionVaishali K Patadia, Martijn J Schuemie, Preciosa Coloma, et al.
Drug Safety|February 24, 2024
The Role of the European Medicines Agency in the Safety Monitoring of COVID-19 Vaccines and Future Directions in Enhancing Vaccine Safety GloballyIrina Caplanusi, Agnieszka Szmigiel, Menno van der Elst, et al.
British Journal of Clinical Pharmacology|May 7, 2011
Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatmentMartina Teichert, Loes E Visser, Andrė G Uitterlinden, et al.
The Oncologist|March 11, 2020
EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid TumorsDominik Karres, Sahra Ali, Paula B van Hennik, et al.
British Journal of Haematology|March 23, 2011
Proton pump inhibitors and the risk of overanticoagulation during acenocoumarol maintenance treatmentMartina Teichert, Charlotte van Noord, Andrė G Uitterlinden, et al.
ACS Pharmacology & Translational Science|August 14, 2025
Applying the EU Regulatory Framework to Determine the Benefit-Risk Profile of PsychedelicsKate Browne, Ewa Bałkowiec-Iskra, Andre Elferink, et al.
Drug Safety|August 22, 2018
Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint ActionAnna Radecka, Louise Loughlin, Mick Foy, et al.
Clinical Pharmacology and Therapeutics|July 4, 2024
Real-World Evidence to Support EU Regulatory Decision Making-Results From a Pilot of Regulatory Use CasesStefanie Prilla, Sophie Groeneveld, Alexandra Pacurariu, et al.
Pageof 3